Biote Corporation reports third quarter revenue of $48.0 million and net income of $9.2 million
I'm PortAI, I can summarize articles.
Biote Corporation reported third quarter 2025 revenue of $48.0 million, down 6.7% from the previous year. Procedure revenue decreased by 10.4%, while dietary supplements revenue increased by 8.4%. Gross profit margin improved to 71.8%. Net income was $9.2 million, with diluted earnings per share of $0.22, compared to $12.7 million and $0.33 per share last year. Adjusted EBITDA fell 20.5% to $12.9 million, and the company repurchased about one million shares, maintaining its 2025 financial guidance.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments